Dr. Hamid is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
880 Madison Ave
Oncology Clinic 4 floor
Memphis, TN 38103Phone+1 901-545-6969Fax+1 901-545-8122
Summary
- I am second year fellow training at Karmanos Cancer Institute in Detroit and will graduate by June 2020.
Education & Training
Detroit Medical Center/Wayne State UniversityFellowship, Hematology and Medical Oncology, 2017 - 2020- Detroit Medical Center/Wayne State UniversityFellowship, Internal Medicine, 2020
- Detroit Medical CenterInternal Medicine, 2020
- Detroit Medical Center/Wayne State UniversityResidency, Internal Medicine, 2014 - 2017
Aga Khan Medical CollegeClass of 2010
Certifications & Licensure
TN State Medical License 2020 - 2026
MI State Medical License 2017 - 2021- American Board of Internal Medicine Internal Medicine
Publications & Presentations
PubMed
- 19 citationsCheckpoint blockade treatment sensitises relapsed/refractory non-Hodgkin lymphoma to subsequent therapyNicole A. Carreau, Philippe Armand, Reid W. Merryman, Ranjana H. Advani, Michael A. Spinner
British Journal of Haematology. 2020-10-01 - 26 citationsCheckpoint Blockade Treatment May Sensitize Hodgkin Lymphoma to Subsequent Therapy.Nicole A. Carreau, Orrin Pail, Philippe Armand, Reid W. Merryman, Ranjana H. Advani
The Oncologist. 2020-10-01 - 6 citationsRisk of anemia attributable to everolimus in patients with cancer: a meta-analysis of randomized controlled trials.Raji Shameem, Muhammad Saad Hamid, Shenhong Wu
Anticancer Research. 2015-04-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
